Abstract: A jig assembly for selecting and presenting fastener nuts in the correct orientation, each fastener nut including a nut cap and an assembling portion formed on an end of the fastener nut. The diameter of the nut cap is larger than the diameter of the assembling portion. The jig assembly includes an electric cabinet, a jig bracket, a feed container, and a sorting tray. The feed container includes a selector with an opening. The width of the opening is equal to the height of the fastener nut, the first sidewall of the selector forms a plurality of restricting protrusions, and each two adjacent restricting protrusions cooperatively define a restricting groove therebetween. The width of each restricting groove is equal to the diameter of the assembling portion, thus only fastener nuts in the correct orientation are capable of passing through the selector to be collected in the sorting tray.

Abstract: A card edge connector for receiving a card which is rotatably assembled includes an insulative housing, a plurality of terminals and a pair of metal pieces. The insulative housing has a inserted slot for receiving the card and a key within the inserted slot for anti-mismating of the card. The terminals are arranged in a single row and located at one side of the inserted slot. Each terminal includes a solder portion extending out of the insulative housing and a contacting portion projecting into the inserted slot. The metal pieces locate at the other side of the inserted slot, each of which includes a mounting portion and an abutting portion projecting into the inserted slot. The terminals are arranged in a single row for reducing the height of the card edge connector.

Abstract: This invention relates to multicyclic compounds, pharmaceutical compositions comprising them, and methods of their use in, for example, the treatment of cognitive disorders.

Abstract: The invention provides certain cycloalkyl-fused tetrahydroquinolines of the Formula (I), and their pharmaceutically acceptable salts and esters, wherein R1, R2, R7, R8a, E, Y, Z, n, u, and t are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with uncontrolled or inappropriate stimulation of CRTH2 function.

Abstract: This invention relates to the cleaning of flue gas released from various combustion processes, particularly a surface deposition NH3—SCR honeycomb catalyst and its preparation method. The catalyst is composed of framework material, TiO2, V2O5 and WO3, wherein the framework material is composed of clay, coal ash, mineral waste residue or their mixture. The mass fractions for framework material, TiO2, V2O5, and WO3 are 60 wt. % to 80 wt. %, 13 wt. % to 33 wt. %, 1 wt. % to 5 wt. %, and 0.1 wt. % to 2 wt. %, respectively.

Abstract: In accordance with various embodiments, there is provided a work light, which includes a housing, a light source including one of a light-emitting diode and a compact fluorescent light, and a light assembly including a plurality of light-emitting diodes. The work light further includes a power source, and a light focusing mechanism including a slide switch. The slide switch controls a focus distance of light emitted from the light source. The light focusing mechanism is configured to focus light emitted from the light source, when the slide switch is positioned in a first position, and configured to scatter light emitted from the light source, when the slide switch is positioned in a second position.

Abstract: Polyamidoamine, its partially degraded products or its complexes-Math1 gene nanoparticles, method for preparing the same and use thereof, the gene nanoparticles can be produced through complex coacervating of polyamidoamine, or polyamidoamine complexes and a Math1 gene-containing plasmid. The gene nanoparticles are controllable in particle size, uniform in size, favorable for surface modification, can enhance the ability of expression and delivery of the Math1 gene, and is useful in a sensorineural hearing loss caused by hair cells loss due to noise, drug toxicity etc.

Abstract: Disclosed herein are the methods to improve the electrical conductivity for micro-moulded plastic parts containing carbon nanotubes. The polymer/carbon nanotubes composites suitable for polymer micromoulding including 80˜99.95 wt % of a polymer pellet or powder, 0-2 wt % of antioxidant, 0-2 wt % of dispersant agent and 0.05-20 wt % of carbon nanotube with a diameter 0.5-200 nm and a length of 200 nm-20 ?m are firstly prepared through melt extrusion. The plastic microparts are prepared by micromoulding of the polymer/carbon nanotubes composites including micro extrusion, micro injection and hot embossing at optimized processing conditions and then are subject to a post thermal treatment to enhance the electrical conductivity. The post thermal treatment methods include electric heating, microwave, infrared or plasma heating.

Abstract: In accordance with various embodiments, there is provided a light-emitting diode lamp, which includes a body shell, and a light source assembly arranged in a cavity of the body shell. The light source assembly includes a light-emitting diode. The light-emitting diode lamp further includes a thermosensitive sensor, and a photosensitive sensor. The thermosensitive sensor and the photosensitive sensor are independently and automatically configured to detect, respectively, a presence of a person and ambient light near the light-emitting diode lamp.

Abstract: The invention provides certain cycloalkyl-fused tetrahydroquinolines of the Formula (I), and their pharmaceutically acceptable salts and esters, wherein R1, R2, R7, R8, R8a, E, Y, Z, n, u, and t are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with uncontrolled or inappropriate stimulation of CRTH2 function.

Abstract: The invention provides certain quinoxalines and aza-quinoxalines of the Formula (I), and their pharmaceutically acceptable salts, wherein J1, J2, R1, R2, R3, R22, Ra, Rb, Rc, Rd, X, Y, b, n, and q are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions associated with uncontrolled or inappropriate stimulation of CRTH2 function.

Abstract: In accordance with various embodiments, there is provided a light-emitting diode work light, which includes a housing, a light source comprising a light-emitting diode, and a light focusing assembly comprising a lens and a focusing knob. The light focusing assembly is configured to adjust a focal distance of light emitted from the light source. The focusing knob is configured to adjust a distance between the light source and the lens. In accordance with certain embodiments, the light-emitting diode work light includes a plurality of lights sources and a plurality of light focusing assemblies. Each light focusing assembly includes a lens and a focusing knob, and is configured to adjust a focal distance of light emitted from a respective light source.

Abstract: In its many embodiments, the present invention provides a novel class of biaryl spiroaminooxazoline analogues as modulators of ?2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the ?2C adrenergic receptors using such compounds or pharmaceutical compositions.

Abstract: Provided herein are methods and materials for diagnosing an esophageal or esophageal-related disorder, or a predisposition for such disorders, in a subject. The methods center on detecting a genetic or protein esophageal marker. An esophageal marker has been identified in the PLCE1 gene and may be useful in predicting disease progression and assessing the subject's response to therapy.

Abstract: This application provides for compounds of the formula Formula I or a pharmaceutically acceptable salt thereof, wherein the individual variables are defined herein, as well as processes to prepare these compounds, pharmaceutical compositions comprising the same and their use in treating disease state associated with the CRTH2 receptor.

Abstract: The present disclosure is generally directed to compounds which can modulate G-protein coupled receptor 88, compositions comprising such compounds, and methods for modulating G-protein coupled receptor 88.

Abstract: In its many embodiments, the present invention provides a novel class of biaryl spiroaminooxazoline analogues as modulators of ?2C adrenergic receptor agonists, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more conditions associated with the ?2C adrenergic receptors using such compounds or pharmaceutical compositions.

Abstract: A heat exchanger radiating fin structure and a heat exchanger thereof. The radiating fin includes a main body and at least one rib. The main body has a first plane face and at least one lateral side. Multiple depressions are formed on the first plane face. The rib is disposed on a portion of the first plane face, which portion is free from any of the depressions. The rib obliquely extends in a direction neither normal nor parallel to any lateral side of the first plane face. The heat exchanger includes a radiating fin assembly composed of multiple piled up radiating fins. Each two adjacent radiating fins define therebetween a flow way having at least one inlet and at least one outlet. With the depressions and the rib, the structural strength of the radiating fin is increased and the heat exchange performance of the heat exchanger is enhanced.

Abstract: A card edge connector for receiving a card which is rotatably assembled includes an insulative housing, a plurality of terminals and a pair of metal pieces. The insulative housing has a inserted slot for receiving the card and a key within the inserted slot for anti-mismating of the card. The terminals are arranged in a single row and located at one side of the inserted slot. Each terminal includes a solder portion extending out of the insulative housing and a contacting portion projecting into the inserted slot. The metal pieces locate at the other side of the inserted slot, each of which includes a mounting portion and an abutting portion projecting into the inserted slot. The terminals are arranged in a single row for reducing the height of the card edge connector.